ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients

Journal of Surgical Research

Volumn 170, Issue 2, 2011, Pages 226-232

  Tachezy, Michael ^a   Zander, Hilke ^a   Marx, Andreas H ^a   Gebauer, Florian ^a   Rawnaq, Tamina ^a   Kaifi, Jussuf T ^b   Sauter, Guido ^a   Izbicki, Jakob R ^a   Bockhorn, Maximilian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

ALCAM; biomarker; PNET; prognosis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; HORMONE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; NEUROENDOCRINE TUMOR; PANCREAS CANCER; PANCREAS NEUROENDOCRINE TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TISSUE MICROARRAY;

ADULT; AGED; ANTIGENS, CD; CELL ADHESION MOLECULES, NEURONAL; FEMALE; FETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80052817626     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.06.002     Document Type: Article

References (36)

1. T.R. Halfdanarson, J. Rubin, and M.B. Farnell Pancreatic endocrine neoplasms: Epidemiology and prognosis of pancreatic endocrine tumors Endocr Relat Cancer 15 2008 409
2. J.C. Yao, M. Hassan, and A. Phan One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063
3. S. van Eeden, and G.J. Offerhaus Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors Virchows Arch 448 2006 1
4. G. Kloppel, A. Perren, and P.U. Heitz The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification Ann N Y Acad Sci 1014 2004 13
5. G. Rindi, G. Kloppel, and H. Alhman TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system Virchows Arch 449 2006 395
6. C.S. Verbeke Endocrine tumours of the pancreas Histopathology 56 2010 669
7. M. Ihnen, V. Muller, and R.M. Wirtz Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 2008 419
8. W. Weichert, T. Knosel, and J. Bellach ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 2004 1160
9. D. Mezzanzanica, M. Fabbi, and M. Bagnoli Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 2008 1726
10. J.W. van Kilsdonk, R.H. Wilting, and M. Bergers Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule Cancer Res. 68 2008 3671
11. C. Kahlert, H. Weber, and C. Mogler Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse Br J Cancer 101 2009 457
12. S.F. Ofori-Acquah, and J.A. King Activated leukocyte cell adhesion molecule: A new paradox in cancer Transl Res 151 2008 122
13. U.H. Weidle, D. Eggle, and S. Klostermann ALCAM/CD166: Cancer-related issues Cancer Genomics Proteomics 7 2010 231
14. C. Sato, T. Matsuda, and K. Kitajima Neuronal differentiation-dependent expression of the disialic acid epitope on CD166 and its involvement in neurite formation in Neuro2A cells J Biol Chem. 277 2002 45299
15. G.W. Swart Activated leukocyte cell adhesion molecule (CD166/ALCAM): Developmental and mechanistic aspects of cell clustering and cell migration Eur J Cell Biol. 81 2002 313
16. M. Buhusi, G.P. Demyanenko, and K.M. Jannie ALCAM regulates mediolateral retinotopic mapping in the superior colliculus J Neurosci 29 2009 15630
17. H. Vaisocherova, V.M. Faca, and A.D. Taylor Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera Biosens Bioelectron 24 2009 2143
18. V. Kulasingam, Y. Zheng, and A. Soosaipillai Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer Int J Cancer 125 2009 9
19. O. Rosso, T. Piazza, and I. Bongarzone The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells Mol Cancer Res 5 2007 1246
20. J. Ladd, A.D. Taylor, and M. Piliarik Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging Anal Bioanal Chem. 393 2009 1157 1163
21. X. Hong, C.W. Michalski, and B. Kong ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer J Surg Oncol 101 2010 564
22. V.M. Faca, K.S. Song, and H. Wang A mouse to human search for plasma proteome changes associated with pancreatic tumor development PLoS Med 5 2008 e123
23. U. Reichelt, P. Duesedau, and M. Tsourlakis Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus Mod Pathol 20 2007 120
24. T. Kalinina, M. Bockhorn, and J.T. Kaifi Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus Int J Cancer 127 2010 1931
25. D.G. Altman, B. Lausen, and W. Sauerbrei Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 86 1994 829
26. P.G. Schurr, T. Strate, and K. Rese Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: An institutional experience Ann Surg 245 2007 273
27. D.S. Heffron, and J.A. Golden DM-GRASP is necessary for nonradial cell migration during chick diencephalic development J Neurosci 20 2000 2287
28. H. Ott, H. Diekmann, and C.A. Stuermer Function of Neurolin (DM-GRASP/SC-1) in guidance of motor axons during zebrafish development Dev Biol 235 2001 86
29. J.A. Weiner, S.J. Koo, and S. Nicolas Axon fasciculation defects and retinal dysplasias in mice lacking the immunoglobulin superfamily adhesion molecule BEN/ALCAM/SC1 Mol Cell Neurosci 27 2004 59
30. H.X. Avci, P. Zelina, and K. Thelen Role of cell adhesion molecule DM-GRASP in growth and orientation of retinal ganglion cell axons Dev Biol 271 2004 291
31. G. Rindi, and G. Kloppel Endocrine tumors of the gut and pancreas tumor biology and classification Neuroendocrinology 80 Suppl 1 2004 12
32. G. Kristiansen, C. Pilarsky, and C. Wissmann ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions Prostate 54 2003 34
33. M.V. Corrias, C. Gambini, and A. Gregorio Different subcellular localization of ALCAM molecules in neuroblastoma: Association with relapse Cell Oncol 32 2010 77
34. M. Ihnen, N. Kohler, and J.F. Kersten Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases Dis Markers 28 2010 71
35. R. Wachowiak, H.C. Fiegel, and J.T. Kaifi L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors Ann Surg Oncol 14 2007 3575
36. J.T. Kaifi, U. Reichelt, and A. Quaas L1 is associated with micrometastatic spread and poor outcome in colorectal cancer Mod Pathol 20 2007 1183